by Silvia Prades | Sep 6, 2023 | News Articles
CureDRPLA was a proud exhibitor at the International Congress of Parkinson’s Disease and Movement Disorders in Copenhagen, held from August 27-31. This event drew in a remarkable crowd of over 5,200 in-person attendees representing more than 100 countries. This...
by Silvia Prades | Aug 16, 2023 | Announcements
Be among the first to know and become part of our community. Sign up here.
by Silvia Prades | Aug 16, 2023 | News Articles
The FDA, the US regulatory agency for new medicines, declined to review the documents for a potential therapy for SCA3 (type of ataxia) developed by Biohaven. The criteria for approving a drug often rely on standards established for more prevalent conditions, making...
by Silvia Prades | Jul 12, 2023 | Announcements
Rareconnect will retire on 1st December 2023 and we won’t be able to post on the DRPLA community anymore. You can continue getting updates on the following sites:DRPLA Facebook group – https://www.facebook.com/groups/144167217964CureDRPLA Facebook page...
by Silvia Prades | Jul 7, 2023 | Events
Dr Silvia Prades will give an update on the projects funded by CureDRPLA. Followed by a Q&A session with Dr Yael Shiloh-Malawsky from the University of North Carolina and Dr Hector Garcia-Moreno from University College London, experts in DRPLA. This event is...
Recent Comments